Showing results (831-840 of 2,747) with videos related to
Sort By:
Pageof 275
Clinical and Experimental Nephrology|August 2, 2018
Peptiduria: a potential early predictor of diabetic kidney diseaseKrishnamurthy P Gudehithlu, Peter D Hart, Jane Vernik, et al.Clinical and Experimental Nephrology|April 29, 2019
The effects of a participatory structured group educational program on the development of CKD: a population-based studyTadashi Sofue, Yuka Okano, Nao Matsushita, et al.Clinical and Experimental Nephrology|September 27, 2018
Clinical outcome of incident peritoneal dialysis patients with diabetic kidney diseaseKyoko Kishida, Yukio Maruyama, Kana Asari, et al.Clinical and Experimental Nephrology|July 25, 2018
The Japanese clinical practice guideline for acute kidney injury 2016Kent Doi, Osamu Nishida, Takashi Shigematsu, et al.Clinical and Experimental Nephrology|July 25, 2018
Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillanceShuichi Ito, Yoshihiko Hidaka, Norimitsu Inoue, et al.Clinical and Experimental Nephrology|August 3, 2018
Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort StudyTakeshi Hasegawa, Kentaro Sakamaki, Fumihiko Koiwa, et al.Clinical and Experimental Nephrology|October 13, 2021
Epidemiology and temporal changes in the prognosis of rapidly progressive glomerulonephritis in Japan: a nationwide 1989-2015 surveyShuzo Kaneko, Kunihiro Yamagata, Joichi Usui, et al.Clinical and Experimental Nephrology|July 23, 2022
Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency departmentHirofumi Sumi, Naohiko Imai, Yugo ShibagakiClinical and Experimental Nephrology|April 26, 2022
Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trialShiro Komiya, Mari Katsumata, Moe Ozawa, et al.Clinical and Experimental Nephrology|June 20, 2019
Histopathological and proteomic analyses identify integrin-β1 as a potential mediator of phlebosclerosis in uremic patientsChunyu Zhou, Changbin Li, Qiang Wang, et al.Pageof 275